Tag Archives: Jeff Johnson

Zimmer Biomet Holdings (ZBH) Gets a Buy Rating from Robert W. Baird

Robert W. Baird analyst Jeff Johnson maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report) on September 3. The company’s shares closed last Monday at $141.00. According to TipRanks.com, Johnson is a 5-star analyst with an average

Patterson Companies (PDCO) Receives a Hold from Robert W. Baird

Robert W. Baird analyst Jeff Johnson reiterated a Hold rating on Patterson Companies (PDCO – Research Report) today and set a price target of $22.00. The company’s shares closed last Monday at $23.10. According to TipRanks.com, Johnson is a 5-star

Analysts Are Bullish on Top Healthcare Stocks: Stryker Corporation (SYK), Exact Sciences (EXAS)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stryker Corporation (SYK – Research Report) and Exact Sciences (EXAS – Research Report) with bullish sentiments. Stryker Corporation (SYK) In a report

Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA Inc (NASDAQ: XRAY), Petiq Inc (NASDAQ: PETQ) and Antares Pharma (NASDAQ: ATRS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on DENTSPLY SIRONA Inc (XRAY – Research Report), Petiq Inc (PETQ – Research Report) and Antares Pharma (ATRS – Research Report). DENTSPLY SIRONA Inc (XRAY) In

Robert W. Baird Reiterates a Hold Rating on Varian Medical Systems

Robert W. Baird analyst Jeff Johnson reiterated a Hold rating on Varian Medical Systems (NYSE: VAR) today and set a price target of $119. The company’s shares opened today at $116.45. According to TipRanks.com, Johnson is a 5-star analyst with

Tandem Diabetes Receives a Buy from Robert W. Baird

In a report released today, Jeff Johnson from Robert W. Baird reiterated a Buy rating on Tandem Diabetes (NASDAQ: TNDM), with a price target of $31. The company’s shares closed on Friday at $26.89, close to its 52-week high of